Insider · CIK 0001362743

Markham Richard J

Reports to the SEC for 5 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001362743

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-06-12	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2019-06-12	VXRTVaxart, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.7K sh	—	—	12,700
2018-02-13	VXRTVaxart, Inc.A Award	Director	AAward	+30.8M sh	—	—	30,793,670
2015-05-11	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−20.1K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−5,353 sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.2M sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−320K sh	—	—	0
2015-05-11	CoLucid Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.52M sh	—	—	1,520,136
2015-05-11	CoLucid Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+25.4K sh	—	—	25,403
2015-05-05	CoLucid Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+5,954 sh	—	—	5,954
2015-04-30	NephroGenex, Inc.Options to Purchase Common StockA Award	Director, 10% Owner	AAward	+6,870 sh	—	—	6,870
2015-01-12	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+16K sh	—	—	16,041
2015-01-12	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+5,353 sh	—	—	5,353
2015-01-12	CoLucid Pharmaceuticals, Inc.Series B Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+960K sh	—	—	959,872
2015-01-12	CoLucid Pharmaceuticals, Inc.Series C Convertible Preferred StockP Purchase	Director, 10% Owner	PPurchase	+320K sh	—	—	320,295
2014-02-14	NephroGenex, Inc.C Conversion	Director, 10% Owner	CConversion	+2.15M sh	—	—	2,148,365
2014-02-14	NephroGenex, Inc.C Conversion	Director, 10% Owner	CConversion	+890K sh	—	—	3,038,505
2014-02-14	NephroGenex, Inc.A Award	Director, 10% Owner	AAward	+413K sh	—	—	3,451,097
2014-02-14	NephroGenex, Inc.P Purchase	Director, 10% Owner	PPurchase	+790K sh	$12.00	+$9.48M	4,241,097
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−14M sh	—	—	0
2014-02-14	NephroGenex, Inc.8% Convertible Promissory NoteC Conversion	Director, 10% Owner	CConversion	—	—	—	0
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	+5.79M sh	—	—	5,785,962
2014-02-14	NephroGenex, Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−5.79M sh	—	—	0
2013-01-02	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2012-01-03	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2011-05-25	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2011-03-31	Anacor Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2011-01-03	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2010-11-30	Anacor Pharmaceuticals, Inc.C Conversion	Director	CConversion	+1.35M sh	—	—	1,348,313
2010-11-30	Anacor Pharmaceuticals, Inc.C Conversion	Director	CConversion	+103K sh	—	—	1,451,100
2010-11-30	Anacor Pharmaceuticals, Inc.C Conversion	Director	CConversion	+107K sh	—	—	1,558,104
2010-11-30	Anacor Pharmaceuticals, Inc.Series C Preferred StockC Conversion	Director	CConversion	−1.35M sh	—	—	0
2010-11-30	Anacor Pharmaceuticals, Inc.Series D Preferred StockC Conversion	Director	CConversion	−103K sh	—	—	0
2010-11-30	Anacor Pharmaceuticals, Inc.Series E Preferred StockC Conversion	Director	CConversion	−107K sh	—	—	0
2010-03-05	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−10.9K sh	$4.77	−$52.1K	0
2010-01-04	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2009-05-26	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−10K sh	$7.38	−$73.8K	10,923
2009-05-22	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−5,800 sh	$7.50	−$43.5K	20,923
2009-05-20	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−6,000 sh	$7.34	−$44K	26,723
2009-05-15	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−1,338 sh	$7.04	−$9,419.52	32,723
2009-05-13	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−7,028 sh	$7.05	−$49.5K	34,061
2009-05-08	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−10.6K sh	$6.93	−$73.5K	41,089
2009-05-07	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−12.9K sh	$6.91	−$89.1K	51,689
2009-05-06	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−12.1K sh	$6.79	−$82.2K	64,589
2009-03-24	ACURA PHARMACEUTICALS, INCS Sale	Director	SSale	−35K sh	$7.11	−$249K	76,689
2009-01-02	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000
2008-01-24	ACURA PHARMACEUTICALS, INCDirector Stock OptionsA Award	Director	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Jun 144
Markham Richard J0001437749-19-012102
SEC(opens sec.gov)
Feb 154
Markham Richard J0001140361-18-008683
SEC(opens sec.gov)
May 124
CoLucid Pharmaceuticals, Inc.0000911916-15-000187
SEC(opens sec.gov)
May 74
CoLucid Pharmaceuticals, Inc.0000911916-15-000160
SEC(opens sec.gov)
May 44
NephroGenex, Inc.0001362743-15-000003
SEC(opens sec.gov)
Feb 194
NephroGenex, Inc.0001571049-14-000510
SEC(opens sec.gov)

Companies

Address

47 HULFISH STREET, SUITE 310

PRINCETON, NJ, 08542